OpenCompanies

Novalgen Limited

Company number
11621264
Status
Active
Type
Private Limited Company
Incorporated
14 Oct 2018
Nature of business
Research and experimental development on biotechnology
Corporate group
GHL Capital Ltd (6 companies)

Registered office

Argyle House Level 3 Northside
Joel Street
Northwood Hills
HA6 1NW

Previous names

  • Immunocure Limited (until 6 Nov 2018)

Officers

NameRoleAppointedResigned
FISCHER, Laurent, Dr Director 14 May 2026

Control

NameNature of controlNotifiedCeased
Ucl Business Plc Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
9 Jan 2019 16 Aug 2019
Dr Amit Chunilal Nathwani Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
14 Oct 2018 20 Mar 2020
Ghl Capital Ltd Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
22 Jan 2026
Convergys Capital Limited Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
31 May 2019

Accounts

Year ended Net assets Cash Employees
31 Dec 2025 £3,525,355 £1,369,753 0
31 Dec 2024 - £683,203 17
31 Dec 2023 - £2,688,464 19
31 Dec 2022 - £2,600,995 24
31 Dec 2021 - £3,960,282 22
31 Dec 2020 - £4,783,897 10
31 Dec 2019 - £2,380,428 10

Connections

Owned by

Novalgen Limited → Convergys Capital Limited

Controls

Companies at the same address

Data